{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10275",
      "entity_text" : "AR",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0828" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "XREF_BIBR With this rationale in mind, second generation antiandrogens began to be developed by the Sawyers / Jung groups based upon the non steroidal agonist RU59063 through screening for potent antiandrogens lacking agonistic activity in context of AR overexpressing tumors.",
  "reading_complete" : "2020-08-05T22:19:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:17:19Z",
  "trigger" : "overexpressing",
  "evidence" : [ "AR-overexpressing" ],
  "pmc_id" : "3622394",
  "score" : 0
}